MarketInOut Stock Screener Log In | Sign Up

Wockhardt Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:58
Wockhardt Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization292,762 mln
Float77.73 mln
Earnings Date11/02/2026

EPS

25.19
Stretched

P / E

75.96
Speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.51
Likely reliable

Relative Strength

56 / 100
Slightly ahead

Debt / Equity

0.45
Low leverage

Business Description

Wockhardt is an Indian pharmaceutical and biotechnology company founded in 1967 and headquartered in Mumbai, with operations spanning the US, UK, Europe, and several other markets worldwide. The company makes and sells a broad range of medicines, vaccines, and biological drugs, including insulin products, a hepatitis-B vaccine, and treatments for anemia. Wockhardt is also advancing a pipeline of next-generation antibiotics designed to fight drug-resistant bacterial infections, which represent some of the most serious challenges in modern medicine.

Key Fundamentals

EPS25.19
P/E75.96
ROE8.85
RPS225
ROIC6.13
ROA4.85
Interest Cover2.26
EBITDA, mln9,060
EV / EBITDA41.53
EV / EBIT55.34
Revenue, mln35,640
EV / Revenue10.56

Quote Details

Last 1,913.40
Change 28.6 (1.52%)
Open 1,885.00
Volume 490,596
Turnover 938,706,368
Average Volume 683,939

Financial Ratios

Pre-Tax Profit Margin13
Current Ratio1.61
Price / Book6.52
Price / Tangible Book14.35
Price / Cash Flow155
Price / Free Cash Flow539
Debt / Equity0.45
Price / Sales9.66

Financial Strength

Altman Z-Score7.31
Piotroski F-Score 6 / 9
Beneish M-Score-2.51
Price to Intrinsic Value9.92
Price to Graham Number8.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.93% 80 / 100   
1 Month -15.55% 17 / 100   
2 Months 0.9% 73 / 100   
6 Months 33.11% 87 / 100   
1 Year 42.5% 89 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog